Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Plos Genetics|April 11, 2019
Novel AU-rich proximal UTR sequences (APS) enhance CXCL8 synthesis upon the induction of rpS6 phosphorylationZhiwei Ang, Ricky Abdi Gunawan Koean, Jun Zhi Er, et al.
Molecules (Basel, Switzerland)|December 11, 2025
Directed Evolution of AtMP2 Peptide: Unlocking Enhanced Antibacterial Potential from Anabas testudineusLi Ting Lee, Arnold Ang, Ahmed Najm, et al.
Polymers|April 11, 2019
Electrochromic Devices Based on Poly(2,6-di(9H-carbazol-9-yl)pyridine)-Type Polymer Films and PEDOT-PSSChung-Wen Kuo, Bo-Wei Wu, Jeng-Kuei Chang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 20, 2019
Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapyHan-Siong Toh, Chun-Ting Yang, Kai-Li Yang, et al.
Journal of Healthcare Engineering|February 21, 2020
Effects of Highly Oxygenated Water in a Hyperuricemia Rat ModelChih-Hsiang Fang, Cheng-Chia Tsai, Yan-Jye Shyong, et al.
Frontiers in Cardiovascular Medicine|August 6, 2024
Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysisI-Ning Yang, Chi-Ya Huang, Chun-Ting Yang, et al.
ACS Nano|April 9, 2015
Ultrastrong Mode Confinement in ZnO Surface Plasmon NanolasersYu-Hsun Chou, Bo-Tsun Chou, Chih-Kai Chiang, et al.
Cardiovascular Diabetology|October 10, 2021
Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific regionChia-Te Liao, Chun-Ting Yang, Han Siong Toh, et al.
Medicine|January 3, 2023
Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trialsMei-Chuan Lee, Yi-Ming Hua, Chun-Ting Yang, et al.
Frontiers in Cardiovascular Medicine|November 15, 2021
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific RegionChia-Te Liao, Chun-Ting Yang, Fang-Hsiu Kuo, et al.
Pageof 8